Magellan Health (Magellan Health) EV-to-EBITDA : 16.78 (As of Apr. 25, 2024)

Magellan Health EV-to-EBITDA Chart

Magellan Health Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
EV-to-EBITDA		Get a 7-Day Free Trial					6.82	8.96	7.24	12.66	13.72

Magellan Health Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
EV-to-EBITDA	Get a 7-Day Free Trial															14.89	13.72	15.20	19.46	16.68

Competitive Comparison of Magellan Health's EV-to-EBITDA

For the Healthcare Plans subindustry, Magellan Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Magellan Health's EV-to-EBITDA Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Magellan Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Magellan Health's EV-to-EBITDA falls into.

Magellan Health EV-to-EBITDA Calculation

Magellan Health's EV-to-EBITDA for today is calculated as:

Magellan Health's current Enterprise Value is $2,009 Mil.
Magellan Health's EBITDA for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $120 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Magellan Health  (NAS:MGLN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Magellan Health's PE Ratio for today is calculated as:

Magellan Health's share price for today is $94.99.
Magellan Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.470.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Magellan Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Magellan Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Magellan Health (Magellan Health) Business Description